Minoryx has raised $22.1m from backers including Roche and Chiesi, and will look to advance its lead Orphan disease therapy through clinical testing.

The company has created a folding electric bike and will use the capital to support a full launch of the product.

Restaurant ordering software startup Wynd plans to use the series A round, backed by Orange's corporate venturing arm, to expand and strengthen its platform.

BioWink, the developer of fertility tracking app Clue, previously obtained seed funding from investors including Dr Kade and Groupe Arnault.

Salesforce's strategic investment unit led a $6m extension to the call centre software developer's series A round, which is now sized at $21m.

Opsonix, which is developing therapies for a range of blood-borne infectious diseases, has secured $8m in a Baxter-led series A round.

The pharmaceutical company has added $6.3m to the $17m raised from backers including Novartis, Pfizer and Partners Innovation Fund last year.

The cybersecurity software company has attracted capital from investors including corporates General Electric and Deutsche Telekom.